ArticleHeliyon2024

Which is the best TACE agent for patients with different NLR hepatocellular carcinomas? A systematic review and network meta-analysis.

Shuai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.